As science continues to advance the understanding of how diseases like cancer and diabetes operate in the human body, the models for treatment have increasingly moved away from one-size-fits-all approaches and toward more individualized therapies. For example, City of...
Diabetic kidney disease (DKD) remains one of the most intractable complications of diabetes. Progress has been made using glycemic and blood pressure control, but the search continues for improved treatments for the estimated one in four adults with diabetes who has...
Cambridge, MA-based Pandion Therapeutics inked a license and collaboration deal worth up to $795 million with Japanese-based Astellas Pharma to research, develop and commercialize locally acting immunomodulators for autoimmune diseases of the pancreas. Pandion brings...
At 19 years old, Sarah Hornak was diagnosed with Type 1 diabetes. It has been nearly 15 years since she learned she has the disease, a condition in which the body’s immune cells attack the pancreas, the gland that regulates blood glucose levels by secreting...
More than 1 million children and adults in the United States have type 1 diabetes, according to the American Diabetes Association. The Centers for Disease Control and Prevention (CDC) note that about 5%Trusted Source of all people who...
A multicenter clinical trial has found that a new artificial pancreas system—which automatically monitors and regulates blood glucose levels—has found that the new system was more effective than existing treatments at controlling blood glucose levels in people with...
